BRIEF

on CEGEDIM (EPA:CGM)

Cegedim's Financial Performance in 2025: Rising Profitability Amidst Revenue Challenges

Stock price chart of CEGEDIM (EPA:CGM) showing fluctuations.

In 2025, Cegedim reported consolidated revenue of €649.2 million, a slight decrease of 0.8% from the previous year due to the deconsolidation of INPS and negative currency impacts. Despite this, the company improved its profitability significantly, with adjusted EBITDA increasing by 9.0% to €134.6 million, representing 20.7% of the revenue.

Adjusted operating income saw a remarkable 25.1% rise to €49.4 million, demonstrating efficiency in cost management and internalization of skills. The Group's operating income nearly doubled to €30.2 million driven by cost containment and strategic operational adjustments.

In terms of business units, the Business Services segment and the Cloud & Support division showcased notable growth of 6.9% and 2.6% in revenue, respectively. Meanwhile, the Healthcare segment faced challenges, primarily within the pharmacy business in France, due to structural changes and workforce restructuring.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all CEGEDIM news